|
MRPL9 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62947433324234E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.96442903347361E-12 |
| Normal-vs-Stage2 |
6.572600E-01 |
| Normal-vs-Stage3 |
9.05320263200338E-11 |
| Normal-vs-Stage4 |
1.61830004952179E-09 |
| Stage1-vs-Stage2 |
4.202600E-04 |
| Stage1-vs-Stage3 |
4.947700E-02 |
| Stage1-vs-Stage4 |
6.400700E-04 |
| Stage2-vs-Stage3 |
6.39040000000035E-05 |
| Stage2-vs-Stage4 |
2.13209999999631E-06 |
| Stage3-vs-Stage4 |
1.638440E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62714286489063E-12 |
| Normal-vs-AfricanAmerican |
5.69120000000201E-05 |
| Normal-vs-Asian |
4.215500000182E-07 |
| Caucasian-vs-AfricanAmerican |
2.004200E-01 |
| Caucasian-vs-Asian |
9.943000E-01 |
| AfricanAmerican-vs-Asian |
2.156200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4898999528844E-09 |
| Normal-vs-Female |
8.47100167788994E-14 |
| Male-vs-Female |
7.572800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.06189551280545E-11 |
| Normal-vs-Age(41-60Yrs) |
2.85319545767493E-11 |
| Normal-vs-Age(61-80Yrs) |
9.70879999950824E-07 |
| Normal-vs-Age(81-100Yrs) |
4.406000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.048400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.764600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.192200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.709200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.949600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.784200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.387000E-01 |
| Classical-VS-Follicular |
2.88989998598055E-09 |
| Classical-VS-Other |
1.460640E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
5.96339999999751E-05 |
| Tall-VS-Other |
1.352650E-01 |
| Tall-VS-Normal |
1.28180000003031E-06 |
| Follicular-VS-Other |
4.100800E-01 |
| Follicular-VS-Normal |
8.887000E-01 |
| Other-VS-Normal |
3.819800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.74570000002861E-06 |
| Normal-vs-N1 |
9.56910000127209E-08 |
| N0-vs-N1 |
5.095100E-03 |
|
|
